Ang D - Search Results

1

Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.

Suehara Y, Arcila M, Wang L, Hasanovic A, Ang D, Ito T, Kimura Y, Drilon A, Guha U, Rusch V, Kris MG, Zakowski MF, Rizvi N, Khanin R, Ladanyi M. Suehara Y, et al. Among authors: ang d. Clin Cancer Res. 2012 Dec 15;18(24):6599-608. doi: 10.1158/1078-0432.CCR-12-0838. Epub 2012 Oct 10. Clin Cancer Res. 2012. PMID: 23052255 Free PMC article.

2

Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas.

Paik PK, Johnson ML, D'Angelo SP, Sima CS, Ang D, Dogan S, Miller VA, Ladanyi M, Kris MG, Riely GJ. Paik PK, et al. Among authors: d angelo sp, ang d. Cancer. 2012 Dec 1;118(23):5840-7. doi: 10.1002/cncr.27637. Epub 2012 May 17. Cancer. 2012. PMID: 22605530 Free PMC article.

3

Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers.

Dogan S, Shen R, Ang DC, Johnson ML, D'Angelo SP, Paik PK, Brzostowski EB, Riely GJ, Kris MG, Zakowski MF, Ladanyi M. Dogan S, et al. Among authors: d angelo sp, ang dc. Clin Cancer Res. 2012 Nov 15;18(22):6169-77. doi: 10.1158/1078-0432.CCR-11-3265. Epub 2012 Sep 26. Clin Cancer Res. 2012. PMID: 23014527 Free PMC article.

4

Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinoma.

Hasanovic A, Ang D, Moreira AL, Zakowski MF. Hasanovic A, et al. Among authors: ang d. Lung Cancer. 2012 Aug;77(2):299-305. doi: 10.1016/j.lungcan.2012.04.004. Epub 2012 Apr 26. Lung Cancer. 2012. PMID: 22542171

5

KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma.

Rekhtman N, Ang DC, Riely GJ, Ladanyi M, Moreira AL. Rekhtman N, et al. Mod Pathol. 2013 Oct;26(10):1307-19. doi: 10.1038/modpathol.2013.74. Epub 2013 Apr 26. Mod Pathol. 2013. PMID: 23619604 Free PMC article.

6

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.

Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL. Rekhtman N, et al. Among authors: ang dc. Mod Pathol. 2011 Oct;24(10):1348-59. doi: 10.1038/modpathol.2011.92. Epub 2011 May 27. Mod Pathol. 2011. PMID: 21623384 Free article.

7

The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater.

Ang DC, Shia J, Tang LH, Katabi N, Klimstra DS. Ang DC, et al. Am J Surg Pathol. 2014 Oct;38(10):1371-9. doi: 10.1097/PAS.0000000000000230. Am J Surg Pathol. 2014. PMID: 24832159

8

Novel method for PIK3CA mutation analysis: locked nucleic acid--PCR sequencing.

Ang D, O'Gara R, Schilling A, Beadling C, Warrick A, Troxell ML, Corless CL. Ang D, et al. J Mol Diagn. 2013 May;15(3):312-8. doi: 10.1016/j.jmoldx.2012.12.005. Epub 2013 Mar 27. J Mol Diagn. 2013. PMID: 23541593 Free article.

9

Mucinous breast carcinomas lack PIK3CA and AKT1 mutations.

Kehr EL, Jorns JM, Ang D, Warrick A, Neff T, Degnin M, Lewis R, Beadling C, Corless CL, Troxell ML. Kehr EL, et al. Among authors: ang d. Hum Pathol. 2012 Dec;43(12):2207-12. doi: 10.1016/j.humpath.2012.03.012. Epub 2012 Jun 15. Hum Pathol. 2012. PMID: 22705004

10

Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions.

Ang DC, Warrick AL, Shilling A, Beadling C, Corless CL, Troxell ML. Ang DC, et al. Mod Pathol. 2014 May;27(5):740-50. doi: 10.1038/modpathol.2013.197. Epub 2013 Nov 1. Mod Pathol. 2014. PMID: 24186142 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

376 results

Search Page

Filters